|
Issue |
Title |
|
Online First |
Factors, markers, diagnostic methods, and prediction of pregnancy loss |
Abstract
PDF (Rus)
|
P. A. Koshulko, A. M. Kirsanova-Martynova, V. A. Buchnev, E. V. Ignatova, S. S. Kupriyanov, E. S. Melnikov, P. A. Solodov, A. M. Dorogova, G. D. Bagirova, A. V. Zubkov, A. D. Kolyvanova, E. A. Zubareva, A. D. Senatskaya |
|
Vol 21, No 1 (2025) |
Remote results of treatment of patients with advanced ovarian cancer after interval and delayed cytoreductive surgery: a retrospective single-center study |
Abstract
PDF (Rus)
|
P. I. Sorokin, D. O. Utkin, M. V. Novozhilov, Z. T. Abduragimova, S. E. Kulikova |
|
Vol 21, No 1 (2025) |
Recurrent high-grade squamous intraepithelial lesion and early-stage cervical cancer (in situ): predictors, long-term treatment outcomes, and opportunities for treatment and prevention |
Abstract
PDF (Rus)
|
A. O. Shumeykina, A. G. Kedrova, E. A. Zhdanova, A. V. Tarkhov, S. E. Krasilnikov |
|
Vol 21, No 1 (2025) |
Efficacy and safety of combination therapy with lenvatinib and pembrolizumab in elderly patients with advanced endometrial cancer |
Abstract
PDF (Rus)
|
M. V. Volkonskiy, A. A. Akopyan, T. A. Zhelezkova, R. S. Zhikhorev, E. P. Krasnorutskaya, N. R. Abidova, T. A. Makarkina, M. O. Skorina, V. M. Filippova, I. A. Luev, Yu. V. Vasilyeva, G. D. Malina, L. P. Veshkina, B. L. Nersesyan |
|
Vol 21, No 1 (2025) |
Comparative characteristics of the effectiveness of therapy with PARP inhibitor in patients with primary ovarian cancer in the Tyumen Region in the period from 2019 to 2023 |
Abstract
PDF (Rus)
|
M. Ya. Kuzmenko, V. V. Zhdanova, V. I. Pavlova, M. S. Shvedskiy |
|
Vol 21, No 1 (2025) |
Clinical and economic evaluation of the effectiveness of modern strategies for screening and early diagnosis of cervical cancer in the Russian Federation |
Abstract
PDF (Rus)
|
Zh. V. Khaylova, V. V. Omelyanovskiy, R. A. Teryan, D. G. Shchurov, I. A. Mikhailov, Yu. I. Komarov, A. D. Kaprin |
|
Vol 21, No 1 (2025) |
Real world outcomes in patients with recurrent, advanced, or metastatic endometrial cancer treated with lenvatinib plus pembrolizumab |
Abstract
PDF (Rus)
|
A. Pawsey, P. Mahalingam, N. Senthivel, A. Ramessur, E. Turnbull, S. Usman, R. Browne, A. Patel, A. Stewart, L. Tookman, N. Counsell, R. Miller, S. Nicum, G. Eminowicz |
|
Vol 20, No 4 (2024) |
Cytological diagnosis of glandular lesions of the cervix |
Abstract
PDF (Rus)
|
O. G. Grigoruk, T. A. Moskvina, L. M. Bazulina, I. V. Vikhlaynov |
|
Vol 20, No 4 (2024) |
Efficacy and safety of lenvatinib plus pembrolizumab in patients with endometrial cancer: data from an extended study of routine clinical practice in Russia |
Abstract
PDF (Rus)
|
A. A. Rumyantsev, A. E. Protasova, A. A. Grechkina, M. V. Volkonskiy, M. R. Mukhitova, O. N. Aymamedova, A. Yu. Goryainova, A. A. Akopyan, A. A. Gofman, T. A. Zhelezkova, R. S. Zhikhorev, E. P. Krasnorutskaya, N. R. Abidova, T. A. Makarkina, V. G. Sisakyan, M. O. Skorina, V. M. Filippova, A. K. Chebodaev, N. M. Chernorubashkina, S. P. Medvedev, D. N. Bubenko, A. S. Antipin, Yu. V. Vasilyeva, N. S. Goloschapova, B. V. Gonchikov, T. V. Davydova, D. V. Khodareva, M. P. Karpovich, T. V. Krashihina, I. Yu. Lots, E. M. Magomedova, A. O. Milyukova, S. T. Nazranova, N. E. Musaeva, N. V. Prokudina, P. R. Rabadanova, N. D. Romanova, O. V. Romanchuk, P. A. Sakulin, R. A. Skotnikov, A. B. Sunyaykin, A. I. Tabakova, E. A. Talalaeva, K. V. Titov, E. E. Tonenkova, Yu. A. Trushina, I. S. Usoltseva, Kh. M. Khabrieva, F. V. Tsarakhova, E. B. Shakhnovich, A. P. Shishkov, A. N. Letuchikh |
|
Vol 20, No 3 (2024) |
Experience of using robot-assisted (da Vinci) operations in the treatment of common endometriosis |
Abstract
PDF (Rus)
|
A. K. Politova, A. D. Aleksandrova, Yu. A. Vershinina, A. A. Politova, M. I. Rokhlina |
|
Vol 20, No 3 (2024) |
Estimation of the girls cost vaccination against human papillomavirus in the Siberian Federal District |
Abstract
PDF (Rus)
|
O. A. Ananina, L. D. Zhuykova, L. A. Kolomiets, E. L. Choinzonov, G. A. Kononova, L. V. Pikalova |
|
Vol 20, No 3 (2024) |
Dynamics of cervical intraepithelial neoplasia according to cytological and morphological data on the example of women’s consultations in Yekaterinburg |
Abstract
PDF (Rus)
|
S. N. Lapikova, K. Kh. Saydullaeva, E. A. Rosyuk |
|
Vol 20, No 3 (2024) |
The long-term clinical efficacy and safety of lenvatinib plus pembrolizumab in endometrial cancer: data from routine clinical practice in Russia |
Abstract
PDF (Rus)
|
A. E. Protasova, A. A. Rumyantsev, M. Yu. Sheremet, A. Yu. Goryainova, M. V. Volkonsky, A. G. Kedrova, S. V. Kuzmicheva, O. N. Aymamedova, Kh. S. Musaeva, S. M. Soroka, O. V. Romanchuk, V. N. Orlova, N. G. Graft, M. R. Ibragimova, Yu. I. Merzlikina, L. V. Stepura, L. B. Tatulova, A. A. Abasova, A. A. Akopyan, E. V. Arsenyeva, Yu. V. Vasilyeva, A. V. Belonogov, L. V. Krivolapova, A. A. Bobryshev, D. Yu. Vovk, I. A. Luev, N. R. Abidova, R. S. Zhikhorev, T. A. Zhelezkova, T. T. Grigoryan, T. A. Makarkina, V. A. Ekimov, A. V. Zhizhina, E. V. Karabina, O. A. Kuchevskaya, V. M. Filippova, T. A. Linchenko, A. A. Lisaeva, A. N. Fedorova, K. S. Maystrenko, E. V. Markizova, E. V. Kogay, E. P. Krasnorutskaya, M. E. Popova, Yu. Yu. Pchelin, R. A. Ryanzhina, D. B. Sidorov, E. B. Shakhnovich, S. M. Alekseev, M. V. Zinkevich, I. O. Belogortsev, V. A. Chubenko, V. M. Moiseenko, N. Kh. Abduloeva, A. A. Lebedinets, L. V. Strakh, L. K. Semenov, M. B. Bolieva, F. Z. Aydaeva |
|
Vol 20, No 2 (2024) |
Tumour budding, MELF-pattern and tumour-infiltrating lymphocytes as possible pathomorphological parameters of the course of endometrioid adenocarcinoma of the uterine corpus |
Abstract
PDF (Rus)
|
D. A. Zinovkin, I. V. Veyalkin, S. L. Achinovich, I. I. Slepokurova, Yu. A. Lyzikova, A. Farooq |
|
Vol 20, No 2 (2024) |
The possibilities of predicting the individual risk of cervical cancer in women of reproductive age using mathematical modeling |
Abstract
PDF (Rus)
|
L. A. Klyukina, E. A. Sosnova, A. A. Ishchenko, M. M. Davydov |
|
Vol 20, No 2 (2024) |
Analysis of the incidence of uterine fibroid in Yekaterinburg |
Abstract
PDF (Rus)
|
O. Yu. Sevostyanova, M. V. Koval, T. V. Chumarnaya, S. R. Belomestnov, N. E. Sevostyanova, T. A. Oboskalova, O. D. Striganova |
|
Vol 20, No 2 (2024) |
Microsatellite instability as a reliable marker of coexisting endometrial cancer in atypical endometrial hyperplasia |
Abstract
PDF (Rus)
|
А. E. Protasova, G. A. Raskin, M. S. Sobivchak |
|
Vol 20, No 1 (2024) |
Comparative analysis of robot-assisted and laparoscopic operations in oncogynecology |
Abstract
PDF (Rus)
|
V. A. Alimov, D. N. Grekov, E. G. Novikova, A. M. Danilov, A. V. Sazhina, P. N. Afanasova, A. Yu. Maslova, N. Yu. Polyakova |
|
Vol 20, No 1 (2024) |
Tumor microenvironment parameters as a predictor of the duration of clinical effectiveness of immunotargeted therapy in advanced or metastatic endometrial cancer: A pilot multicenter observational study |
Abstract
PDF (Rus)
|
A. A. Maltseva, A. Yu. Kalinchuk, N. V. Krakhmal, N. M. Chernorubashkina, E. S. Martynova, R. A. Zukov, A. A. Gofman, A. B. Villert, O. N. Churuksaeva, L. A. Kolomiets, L. A. Tashireva |
|
Vol 19, No 4 (2023) |
Dynamics of medical and statistical indicators of cervical cancer over a 10-year period (2011–2020) in Novokuznetsk |
Abstract
PDF (Rus)
|
S. V. Shramko, N. M. Zhilina, V. N. Dureev |
|
Vol 19, No 4 (2023) |
Features of the systemic influence of cervical cancer on peripheral blood and hemostasis according to the tumor histological subtype |
Abstract
PDF (Rus)
|
T. V. Sushinskaya, N. I. Stuklov, E. V. Schepkina, A. I. Kuznetsov, S. V. Еpifanova, A. D. Kaprin |
|
Vol 19, No 4 (2023) |
Efficacy and safety of lenvatinib and pembrolizumab in the treatment of endometrial cancer: data from routine clinical practice in Russia |
Abstract
PDF (Rus)
|
A. A. Rumyantsev, A. E. Protasova, M. Yu. Sheremet, A. Yu. Goryainova, M. V. Volkonskiy, A. G. Kedrova, S. V. Kuzmicheva, O. N. Aymamedova, Kh. S. Musaeva, S. M. Soroka, O. V. Romanchuk, V. N. Orlova, N. G. Graft, M. R. Ibragimova, Yu. I. Merzlikina, L. V. Stepura, L. B. Tatulova, A. A. Abasova, A. A. Akopyan, E. V. Arsenyeva, Yu. V. Vasilyeva, A. V. Belonogov, L. V. Krivolapova, A. A. Bobryshev, D. Yu. Vovk, I. A. Luev, N. R. Abidova, R. S. Zhikhorev, T. A. Zhelezkova, T. T. Grigoryan, T. A. Makarkina, V. A. Ekimov, A. V. Zhizhina, E. V. Karabina, O. A. Kuchevskaya, V. M. Filippova, T. A. Linchenko, A. A. Lisaeva, A. N. Fedorova, K. S. Maystrenko, E. V. Markizova, E. V. Kogay, E. P. Krasnorutskaya, M. E. Popova, Yu. Yu. Pchelin, R. A. Ryanzhina, D. B. Sidorov, E. B. Shakhnovich, S. M. Alekseev, M. V. Zinkevich, I. O. Belogortsev, V. A. Chubenko, V. M. Moiseenko, N. Kh. Abduloeva, A. A. Lebedinets, L. V. Strakh, L. K. Semenov, M. B. Bolieva, F. Z. Aydaeva |
|
Vol 19, No 2 (2023) |
The role of transarterial chemoembolization with drug-eluting beads “Sphere-Spectrum” in the treatment of primary and recurrent tumors of the female reproductive system complicated by bleeding |
Abstract
PDF (Rus)
|
E. A. Zvezdkina, A. G. Kedrova, D. P. Lebedev, T. A. Greyan, D. N. Panchenkov, Yu. A. Stepanova, S. E. Krasilnikov, K. S. Budennyy |
|
Vol 19, No 2 (2023) |
Clinical and morphological features in patients with advanced endometrial cancer treated with immunotargeting therapy |
Abstract
PDF (Rus)
|
L. A. Kolomiets, M. N. Stakheeva, O. N. Churuksaeva, A. B. Villert, A. L. Chernyshova, V. G. Sisakyan, I. Yu. Lots, N. M. Chernorubashkina, V. N. Zhurman, A. A. Grechkina, E. N. Aleksandrova, N. E. Musaeva, O. V. Diduk, N. A. Bulygina, D. A. Pyatina, I. L. Obraz, A. V. Krechetova, M. A. Danilova, M. A. Khodzhakhova, A. A. Malsteva, N. A. Ermak |
|
Vol 19, No 2 (2023) |
Prognostic significance of atypical/hybrid forms of EpCAM+CD45+ cells in the blood of patients with endometrial cancer |
Abstract
PDF (Rus)
|
E. V. Kaigorodova, I. S. Zavaruev, A. L. Chernyshova, M. Yu. Grishchenko |
|
1 - 25 of 100 Items |
1 2 3 4 > >>
|